Rapid Build in LQDA Short Exposure
Liquidia Corporation (LQDA) has become a primary target for short sellers, with short interest as a percentage of free float climbing to 26.6%. This represents a significant 8.1 percentage point increase over the last week, signaling a rapid accumulation of bearish bets against the $4 billion biotech firm. The speed of this build suggests that institutional investors are aggressively positioning for potential downside, making LQDA one of the most active names in the current short-selling landscape.
Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.